Billing and Claims

Reach the next level of revenue integrity

Brush up on the most recent changes to Medicare’s prior authorization requirements and their operational impact.

Consider how revenue integrity and utilization review teams can work together to meet shared goals.

Gain a fresh perspective on methods to efficiently address patient status changes.

Consider these case studies to understand how to apply condition codes 44 and W2.

Learn how to use regular internal audits and monitoring to boost compliance in revenue integrity areas.

CMS announced an increase in Medicare payment for at-home administration of COVID-19 vaccines. Medicare will now pay $75 per at-home dose, nearly double its previous $40 adminitration rate.

CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.

Jugna J. Shah, MPH, CHRI, discusses why innovative therapies and technologies call for innovations in existing coding, billing, and reimbursement models.

Ronald Hirsch, MD, FACP, CHCQM, CHRI, examines recent changes to commercial payer prior authorization requirements and how it affects revenue integrity.